In 1945, the American Medical Association launched what became one of the most expensive lobbying campaigns in American history. Their target was Harry Truman’s proposal for national health insurance. Their weapon was a single, powerful phrase: socialized medicine.
The campaign worked. And for the next two decades, the AMA deployed the same argument against every federal health proposal that followed. When Medicare finally passed in 1965, the AMA had spent millions of dollars and the better part of twenty years trying to stop it; not because they were indifferent to patients, but because they held a genuine, if self-interested, belief: that government intrusion into the doctor-patient relationship would be the end of medicine as they understood it.
It’s worth pausing on that fear seriously before dismissing it. The physicians who opposed Medicare weren’t simply greedy. Many were animated by something more principled: a concern that a third party sitting between doctor and patient, setting fees, defining procedures, and dictating standards of care, would erode clinical autonomy and ultimately harm patients. The government, in their view, would tell doctors what they could prescribe, what they could charge, and perhaps eventually what they could think.
They were describing a real danger. They just got the villain wrong.
The campaign against Medicare
The AMA’s opposition to Medicare was organized, sustained, and sophisticated. In 1949, the organization hired a public relations firm and spent roughly $1.5 million, an enormous sum at the time, to defeat Truman’s national health proposal. They distributed pamphlets to physicians’ waiting rooms, ran ads in newspapers, and organized doctors’ wives into letter-writing campaigns to Congress. The messaging was consistent: federal involvement in healthcare meant federal control of doctors, and federal control of doctors meant the end of the free practice of medicine.
By the time Medicare was finally debated in earnest in the early 1960s, the AMA had refined its argument. Ronald Reagan, then still a few years away from California’s governorship, cut a recording for the AMA called “Ronald Reagan Speaks Out Against Socialized Medicine.” He warned that Medicare was the first step toward a government that would tell Americans where to live, where to work, and how to spend their time. He was making the AMA’s case: that creeping government control, once begun in healthcare, would not stop there.
“If you don’t [stop Medicare], one of these days you and I are going to spend our sunset years telling our children and our children’s children what it once was like in America when men were free.”
Ultimately, with a new President in the White House, and a new President at the AMA, the ideology shifted and Medicare and Medicaid passed in 1965. The predicted catastrophe of doctors reduced to civil servants, medicine nationalized, clinical freedom extinguished, did not materialize, at least not in the form they feared.
But something else did.
The third party that actually arrived
The AMA’s nightmare scenario was a government bureaucrat standing between physician and patient. What actually emerged was a private bureaucrat, and then, in time, an entire industry of them.
The growth of employer-sponsored private insurance in the postwar decades, accelerated by tax policy that made employer contributions tax-free, gradually inserted a new actor into every clinical encounter. At first the intrusion was modest. Insurers paid claims, set premiums, and mostly stayed out of the exam room. But as costs rose and profits demanded management, that restraint eroded.
By the 1990s, managed care had arrived in force. Health maintenance organizations and their variants introduced prior authorization, restricted formularies, narrow networks, and utilization review. A physician who wanted to prescribe a particular drug, order a particular test, or refer a patient to a particular specialist increasingly needed permission not from a government agency, but from a private one whose primary obligation ran not to patients or physicians, but to shareholders.
The irony is almost too neat. The AMA had argued that government would substitute bureaucratic judgment for clinical judgment. What private insurers built was precisely that substitution, operated for profit. The forms are different. The function is the same.
And then came the pharmaceutical industry
The story doesn’t end with insurers. The pharmaceutical industry developed its own forms of influence over the practice of medicine, ones that operated not through denial and restriction, but through persuasion and incentive.
Through the latter half of the twentieth century, drug companies built elaborate relationships with physicians: speaking fees, conference sponsorships, research funding, direct-to-physician marketing, and, for a time, outright gifts. The goal was the same as any marketing effort, to shape prescribing behavior. The result was that clinical decisions were influenced not only by evidence but by relationships, and those relationships were carefully cultivated by companies with a financial interest in particular outcomes.
This is not a conspiracy theory. It is documented in the industry’s own communications, in congressional testimony, in the academic literature on pharmaceutical marketing and prescribing patterns. The influence was real, measurable, and in some cases (the opioid crisis being the most catastrophic example) genuinely deadly.
The AMA worried about a government official telling a doctor what to prescribe. What they got was a detail representative offering lunch, samples, and a carefully constructed clinical narrative that, over time, shaped what physicians believed was appropriate care.
The comparison that matters
This is not an argument that the AMA’s fears were entirely baseless or that government programs are beyond criticism. Medicare and Medicaid have their own administrative burdens, their own misguided incentives, their own failures of design and execution. The question is not whether government involvement in healthcare is without flaw. The question is: compared to what?
Compared to the system that actually developed. The current system is one in which private insurers deny care based on actuarial models and quarterly earnings pressure, in which pharmaceutical companies set prices unconstrained by any public accountability, in which prior authorization has become so burdensome that physicians routinely describe it as the primary source of burnout in their practices. The feared government alternative looks rather different in retrospect.
Government programs are accountable to voters. They can be changed by legislation. Their administrators can be questioned in public hearings. The private entities that now control so much of American medicine are accountable primarily to capital markets. Their decisions are proprietary. Their criteria for denial are not always disclosed. Their executives are not subject to public oversight in any meaningful sense.
The AMA argued that socialized medicine would compromise the doctor-patient relationship by inserting an outside authority into clinical decisions. Across the following sixty years, outside authorities inserted themselves into clinical decisions on an enormous scale. But they did it in the name of shareholder value rather than public health, and that distinction, it turns out, made the outcome worse rather than better.
What the doctors got right, and what they missed
There is something genuinely worth preserving in the original concern. Clinical autonomy matters. The relationship between a physician and a patient depends on a kind of trust that third-party intrusion can corrode. The fear that medicine might be subordinated to interests other than the patient’s was legitimate.
What the AMA got wrong was its implicit assumption that government was the uniquely dangerous form of external control, and that private alternatives were therefore safe. That assumption was not carefully examined. It was, in part, ideological, rooted in mid-century American suspicion of the state and confidence in markets. And it blinded the profession to a threat that was approaching from a different direction entirely.
American physicians today operate within a system that does much of what the AMA warned about: it limits what they can prescribe, second-guesses their clinical judgment, overrides their referrals, and shapes their practice in ways they did not choose. The entity doing this is not the federal government. It is a constellation of private actors whose interests are, at best, only partially aligned with patient welfare.
The question the AMA never fully grappled with is whether there is a form of external accountability for medical decisions that actually serves patients rather than investors. The fear of government control was so total, and so effective as a political argument, that it crowded out the harder question.
The AMA’s campaign against Medicare is often told as a simple story of self-interest dressed up as principle. That reading is too easy. The physicians who fought Medicare believed, many of them sincerely, that they were protecting something important. They were. They just couldn’t see, in 1965, that the threat would arrive wearing a different uniform; carrying a prior authorization form rather than a government mandate, motivated by a deductible rather than an ideology.
Whether what we have now is better or worse than what they feared is not really a close call. The question worth sitting with is simpler, and harder: what will we do about it now?